项目 | 总数 | 切缘状态 | p | |||
切缘阴性 | 单灶性尖部 阳性 | 单灶性基底部阳性 | 多灶性切缘阳性 | |||
患者总数 | 336 (100%) | 186 (55.4%) | 75 (22.3%) | 29 (8.6%) | 46 (13.7%) |
|
年龄(岁) |
|
|
|
|
| <0.001 |
中位数(范围) | 67 (43~81) | 67 (43~81) | 67 (47~80) | 66 (47~78) | 67.5 (53~81) |
|
平均数(标准差) | 66.92 (6.7) | 67.15 (6.31) | 67.04 (7.21) | 64.52 (7.80) | 67.33 (6.37) |
|
术前PSA (ng/mL) |
|
|
|
|
| 0.039 |
中位数(范围) | 19.37 (0.11~70.90) | 15.80 (0.11~64.70) | 20.20 (0.21~56.00) | 26.72 (0.19~70.90) | 51.31 (0.93~79.80) |
|
平均数(标准差) | 37.20 (59.01) | 29.31 (33.81) | 33.01 (31.34) | 61.10 (157.52) | 60.85 (54.22) |
|
前列腺体积(mL) |
|
|
|
|
| <0.001 |
中位数(范围) | 40.25 (10.47~317.02) | 41.87 (12.93~135.09) | 42.01 (16.52~179.58) | 35.78 (11.17~317.02) | 34.80 (10.47~126.23) |
|
平均数(标准差) | 45.76 (27.63) | 47.04 (22.73) | 45.95 (25.71) | 47.78 (54.53) | 41.36 (21.66) |
|
术后病理Gleason评分(例数,%) |
|
|
|
|
| <0.001 |
6 | 35 (10.4) | 32 (91.4) | 2 (5.7) | 1 (2.9) | 0 (0) |
|
3 + 4 = 7 | 59 (17.6) | 41 (69.5) | 10 (16.9) | 5 (8.5) | 3 (5.1) |
|
4 + 3 = 7 | 52 (15.5) | 30 (57.7) | 18 (34.6) | 1 (1.9) | 3 (5.8) |
|
8~10 | 190 (56.5) | 83 (43.7) | 45 (23.7) | 22 (11.6) | 40 (21.0) |
|
术后病理分期 (例数,%) |
|
|
|
|
| <0.001 |
pT2 | 248 (73.8%) | 163 (65.7) | 52 (21.0) | 21 (8.5) | 12 (4.8) |
|
pT3 | 75 (22.3%) | 20 (26.7) | 21 (28.0) | 6 (8.0) | 28 (37.3) |
|
pT4 | 13 (3.9%) | 3 (23.1) | 2 (15.4) | 2 (15.4) | 6 (46.1) |
|
淋巴结清扫 (例数,%) |
|
|
|
|
| <0.001 |
是 | 113 (33.6%) | 59 (52.2) | 22 (19.5) | 10 (8.8) | 22 (19.5) |
|
否 | 223 (66.4%) | 127 (57.0) | 53 (23.8) | 19 (8.5) | 24 (10.7) |
|
神经侵犯 (例数,%) |
|
|
|
|
| <0.001 |
是 | 202 (60.1%) | 90 (44.6) | 55 (27.2) | 24 (11.9) | 33 (16.3) |
|
否 | 134 (39.9%) | 96 (71.6) | 20 (14.9) | 5 (3.7) | 13 (9.8) |
|
血管侵犯 (例数,%) |
|
|
|
|
| <0.001 |
是 | 34 (10.1%) | 13 (38.2) | 7 (20.6) | 4 (11.8) | 10 (29.4) |
|
否 | 302 (89.9%) | 173 (57.3) | 68 (22.5) | 25 (8.3) | 36 (11.9) |
|
精囊侵犯 (例数,%) |
|
|
|
|
| <0.001 |
是 | 73 (21.7%) | 21 (28.8) | 17 (23.3) | 5 (6.8) | 30 (41.1) |
|
否 | 263 (78.7%) | 165 (62.7) | 58 (22.1) | 24 (9.1) | 16 (6.1) |
|